• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Delayed platelet recovery and mortality after allogeneic stem cell transplantation in children.

作者信息

Wells Joseph R, Kang Guolian, Suliman Ali Y, Li Ying, Akel Salem, Triplett Brandon, Srinivasan Ashok

机构信息

Department of Anesthesiology, University of Kentucky College of Medicine, Lexington, KY, USA.

Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.

出版信息

Bone Marrow Transplant. 2022 Aug;57(8):1347-1349. doi: 10.1038/s41409-022-01726-2. Epub 2022 May 28.

DOI:10.1038/s41409-022-01726-2
PMID:35643941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9429998/
Abstract
摘要

相似文献

1
Delayed platelet recovery and mortality after allogeneic stem cell transplantation in children.儿童异基因干细胞移植后血小板延迟恢复与死亡率
Bone Marrow Transplant. 2022 Aug;57(8):1347-1349. doi: 10.1038/s41409-022-01726-2. Epub 2022 May 28.
2
Day +100 Platelet Count Predicts Survival After Allogeneic Hematopoietic Stem-Cell Transplantation in Children With Hematologic Malignancies.+100天血小板计数可预测血液系统恶性肿瘤患儿异基因造血干细胞移植后的生存情况。
Clin Lymphoma Myeloma Leuk. 2019 May;19(5):e221-e227. doi: 10.1016/j.clml.2019.01.001. Epub 2019 Jan 15.
3
Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome.异基因造血干细胞移植后血小板延迟恢复：与慢性移植物抗宿主病及生存结局的关联。
Hematol Oncol. 2018 Feb;36(1):276-284. doi: 10.1002/hon.2427. Epub 2017 May 5.
4
Risk Factors and Impact of Secondary Failure of Platelet Recovery After Allogeneic Stem Cell Transplantation.异基因干细胞移植后血小板恢复二次失败的危险因素及影响
Biol Blood Marrow Transplant. 2016 Sep;22(9):1678-1683. doi: 10.1016/j.bbmt.2016.06.003. Epub 2016 Jun 8.
5
Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival.异基因移植后血小板恢复延迟：治疗相关死亡率增加和生存预后较差的预测因子。
Bone Marrow Transplant. 2011 Jul;46(7):981-6. doi: 10.1038/bmt.2010.218. Epub 2010 Oct 4.
6
Implication of early lymphocyte recovery after allogeneic hematopoietic stem cell transplantation in children with leukemia.异基因造血干细胞移植后早期淋巴细胞恢复对儿童白血病的影响。
Yonsei Med J. 2013 Jan 1;54(1):62-70. doi: 10.3349/ymj.2013.54.1.62.
7
Successful Use of Hematopoietic Stem Cell Transplantation for 2 Pediatric Cases of Glanzmann Thrombasthenia and Review of the Literature.造血干细胞移植成功治疗2例小儿Glanzmann血小板无力症并文献复习
J Pediatr Hematol Oncol. 2020 Aug;42(6):e521-e526. doi: 10.1097/MPH.0000000000001646.
8
The problem of thrombocytopenia after hematopoietic stem cell transplantation.造血干细胞移植后血小板减少的问题。
Stem Cells. 1996;14 Suppl 1:261-73. doi: 10.1002/stem.5530140734.
9
Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants.脐血和异基因外周血造血细胞移植中血小板和红细胞的利用及输血独立性。
Biol Blood Marrow Transplant. 2011 May;17(5):710-6. doi: 10.1016/j.bbmt.2010.08.017. Epub 2010 Oct 14.
10
CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation.CD41+和CD42+造血祖细胞可能预测异基因外周血干细胞移植后的血小板植入情况。
J Clin Apher. 2001;16(2):67-73. doi: 10.1002/jca.1015.

引用本文的文献

1
Recombinant human thrombopoietin safety and efficacy in pediatric allogeneic hematopoietic stem cell transplantation: A cohort study.重组人血小板生成素在儿童异基因造血干细胞移植中的安全性和有效性：一项队列研究。
World J Stem Cells. 2025 Jul 26;17(7):106579. doi: 10.4252/wjsc.v17.i7.106579.
2
Hypermethylation of DNA impairs megakaryogenesis in delayed platelet recovery after allogeneic hematopoietic stem cell transplantation.DNA的高甲基化会损害异基因造血干细胞移植后血小板延迟恢复过程中的巨核细胞生成。
Sci Adv. 2025 May 9;11(19):eads3630. doi: 10.1126/sciadv.ads3630. Epub 2025 May 7.
3
Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants.非选择性β-肾上腺素能受体抑制剂会损害小鼠和人类造血细胞移植后的造血再生。
Cancer Discov. 2025 Apr 2;15(4):748-766. doi: 10.1158/2159-8290.CD-24-0719.
4
What causes aplastic anaemia?什么导致再生障碍性贫血？
Leukemia. 2023 Jun;37(6):1191-1193. doi: 10.1038/s41375-023-01892-2. Epub 2023 Apr 27.

本文引用的文献

1
Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome.异基因造血干细胞移植后血小板延迟恢复：与慢性移植物抗宿主病及生存结局的关联。
Hematol Oncol. 2018 Feb;36(1):276-284. doi: 10.1002/hon.2427. Epub 2017 May 5.
2
Effect of Total Nucleated and CD34(+) Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.有核细胞总数和CD34(+)细胞剂量对异基因造血干细胞移植后结局的影响。
Biol Blood Marrow Transplant. 2015 May;21(5):889-93. doi: 10.1016/j.bbmt.2015.01.025. Epub 2015 Feb 4.
3
No impact of total or myeloid Cd34+ cell numbers on neutrophil engraftment and transplantation-related mortality after allogeneic pediatric bone marrow transplantation.在异基因小儿骨髓移植后，总Cd34+细胞数或髓系Cd34+细胞数对中性粒细胞植入及移植相关死亡率无影响。
Biol Blood Marrow Transplant. 2014 May;20(5):676-83. doi: 10.1016/j.bbmt.2014.01.026. Epub 2014 Jan 31.
4
Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival.异基因移植后血小板恢复延迟：治疗相关死亡率增加和生存预后较差的预测因子。
Bone Marrow Transplant. 2011 Jul;46(7):981-6. doi: 10.1038/bmt.2010.218. Epub 2010 Oct 4.
5
Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover.异基因造血干细胞移植后血小板减少持续存在：与血小板生成受损及血小板周转率增加的关联
Bone Marrow Transplant. 2006 Sep;38(5):377-84. doi: 10.1038/sj.bmt.1705444.
6
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow.急性髓细胞白血病中用于基因相同的异基因干细胞移植的骨髓与外周血：剂量和干细胞来源的影响显示富含骨髓的移植效果更好。
Blood. 2003 Oct 15;102(8):3043-51. doi: 10.1182/blood-2003-03-0665. Epub 2003 Jun 26.
7
Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses.在接受高剂量CD34细胞的 HLA 匹配的骨髓或外周血干细胞移植受者中，治疗失败率降低。
Br J Haematol. 2003 Jun;121(6):874-85. doi: 10.1046/j.1365-2141.2003.04364.x.
8
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey.首次完全缓解的急性髓系白血病患者骨髓细胞剂量对异基因移植结局的相关性：一项欧洲调查结果
J Clin Oncol. 2002 Nov 1;20(21):4324-30. doi: 10.1200/JCO.2002.11.058.
9
Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation.人类白细胞抗原（HLA）相合同胞骨髓移植后CD34细胞剂量与造血恢复、感染及其他结局的相关性
Blood. 2002 Apr 15;99(8):2726-33. doi: 10.1182/blood.v99.8.2726.
10
CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies.对于血液系统恶性肿瘤患者接受异基因骨髓移植后，CD34+细胞剂量可预测生存率、移植后发病率及血液学恢复速率。
Blood. 1996 Oct 15;88(8):3223-9.